Literature DB >> 19505805

Diospyrone, crassiflorone and plumbagin: three antimycobacterial and antigonorrhoeal naphthoquinones from two Diospyros spp.

Victor Kuete1, Jean G Tangmouo, J J Marion Meyer, Namrita Lall.   

Abstract

The aim of this study was to evaluate the antimycobacterial and antigonorrhoeal activities of three naphthoquinones (diospyrone, crassiflorone and plumbagin) from Diospyros canaliculata and Diospyros crassiflora as well as the crude extracts from these plants. The agar disk diffusion assay, broth microdilution method, microplate Alamar blue assay (MABA) and radiometric respiratory technique using the BACTEC 460 TB system were used. Results of the antimycobacterial assays indicated that the minimal inhibitory concentrations (MICs) and minimal bactericidal concentrations ranged from 1.22 microg/mL to 39.06 microg/mL for Mycobacterium smegmatis and all studied Mycobacterium tuberculosis strains for the crude extract from D. crassiflora, diospyrone and crassiflorone. Results of the killing rate experiment revealed that a total inhibition effect on M. tuberculosis H37Rv strain was observed at Day 18 for D. crassiflora and Day 21 for the crude extract from D. canaliculata and diospyrone at 4x MIC as determined by MABA. Results of the antigonorrhoeal assay indicated that diospyrone was able to prevent the growth of all studied strains of Neisseria gonorrhoeae. The overall results of this work provide evidence that the studied plant extracts (diospyrone, crassiflorone and plumbagin) might be potential sources of new antimicrobial drugs against tuberculosis and gonorrhoea.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19505805     DOI: 10.1016/j.ijantimicag.2009.04.008

Source DB:  PubMed          Journal:  Int J Antimicrob Agents        ISSN: 0924-8579            Impact factor:   5.283


  8 in total

1.  Efflux pumps are involved in the defense of Gram-negative bacteria against the natural products isobavachalcone and diospyrone.

Authors:  Victor Kuete; Bathélémy Ngameni; Jean G Tangmouo; Jean-Michel Bolla; Sandrine Alibert-Franco; Bonaventure T Ngadjui; Jean-Marie Pagès
Journal:  Antimicrob Agents Chemother       Date:  2010-02-16       Impact factor: 5.191

Review 2.  Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future.

Authors:  Magnus Unemo; William M Shafer
Journal:  Clin Microbiol Rev       Date:  2014-07       Impact factor: 26.132

3.  Imbalance of the antioxidative system by plumbagin and Plumbago indica L. extract induces hepatotoxicity in mice.

Authors:  Nadta Sukkasem; Waranya Chatuphonprasert; Nitima Tatiya-Aphiradee; Kanokwan Jarukamjorn
Journal:  J Intercult Ethnopharmacol       Date:  2016-03-24

4.  Targeting of Helicobacter pylori thymidylate synthase ThyX by non-mitotoxic hydroxy-naphthoquinones.

Authors:  Stéphane Skouloubris; Kamel Djaout; Isabelle Lamarre; Jean-Christophe Lambry; Karine Anger; Julien Briffotaux; Ursula Liebl; Hilde de Reuse; Hannu Myllykallio
Journal:  Open Biol       Date:  2015-06       Impact factor: 6.411

5.  Antibacterial and antibiotic-potentiation activity of the constituents from aerial part of Donella welwitshii (Sapotaceae) against multidrug resistant phenotypes.

Authors:  Michel-Gael F Guefack; Marcelle O Ngangoue; Armelle T Mbaveng; Paul Nayim; Jenifer R N Kuete; Carine M N Ngaffo; Godloves F Chi; Bathelemy Ngameni; Bonaventure T Ngadjui; Victor Kuete
Journal:  BMC Complement Med Ther       Date:  2022-07-20

6.  Plumbagin induces the apoptosis of human tongue carcinoma cells through the mitochondria-mediated pathway.

Authors:  Jia-xuan Qiu; Yuan-qiao He; Yong Wang; Ru-liang Xu; You Qin; Xiang Shen; Shu-Feng Zhou; Zong-fu Mao
Journal:  Med Sci Monit Basic Res       Date:  2013-08-28

7.  Plumbagin analogs-synthesis, characterization, and antitubercular activity.

Authors:  Nishi Nayak; Meenakshi Bajpai; Balkishen Razdan
Journal:  J Adv Pharm Technol Res       Date:  2014-01

8.  In vitro antibacterial and antibiotic-potentiation activities of the methanol extracts from Beilschmiedia acuta, Clausena anisata, Newbouldia laevis and Polyscias fulva against multidrug-resistant Gram-negative bacteria.

Authors:  Simplice B Tankeo; Pierre Tane; Victor Kuete
Journal:  BMC Complement Altern Med       Date:  2015-11-22       Impact factor: 3.659

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.